Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

NCT07142252 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT07142252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07142252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 2
Overall status
Recruiting
Start date
May 14, 2026
Completion date
May 25, 2028
Enrollment
66 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus